Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2: Treatment

Walter Ageno, David Garcia, Maria I. Aguilar, James Douketis, Guido Finazzi, Davide Imberti, Alfonso Iorio, Nigel S. Key, Wendy Lim, Marco Marietta, Domenico Prisco, Ravi Sarode, Sophie Testa, Alberto Tosetto, Mark Crowther

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Major bleeding complicates oral vitamin K antagonist therapy in 1-3% of patients annually. However, there is a paucity of published research, which provides evidence to guide management of bleeding. To assist physicians dealing with these potentially serious events in their daily clinical practice, we assembled a panel of international experts and posed them a series of focused clinical questions. The experts were asked to perform a systematic literature review and summarize the results of that review within the context of their clinical question. In most cases, data were lacking and the experts were asked to supplement their answer with clinical expertise. To minimize bias, the reviews were vetted by members of the Italian Society for Studies on Hemostasis and Thrombosis, the Federation of Centers for the Diagnosis of Thrombosis and Surveillance of Antithrombotic Therapies, and the Anticoagulation Forum. Our goal in this project is to provide "best evidence" to assist clinicians faced with actively bleeding patients.

Original languageEnglish (US)
Pages (from-to)584-588
Number of pages5
JournalAmerican Journal of Hematology
Volume84
Issue number9
DOIs
StatePublished - Sep 2009

Fingerprint

Vitamin K
Hemorrhage
Thrombosis
Hemostasis
Therapeutics
Physicians
Research

ASJC Scopus subject areas

  • Hematology

Cite this

Ageno, W., Garcia, D., Aguilar, M. I., Douketis, J., Finazzi, G., Imberti, D., ... Crowther, M. (2009). Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2: Treatment. American Journal of Hematology, 84(9), 584-588. https://doi.org/10.1002/ajh.21469

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2 : Treatment. / Ageno, Walter; Garcia, David; Aguilar, Maria I.; Douketis, James; Finazzi, Guido; Imberti, Davide; Iorio, Alfonso; Key, Nigel S.; Lim, Wendy; Marietta, Marco; Prisco, Domenico; Sarode, Ravi; Testa, Sophie; Tosetto, Alberto; Crowther, Mark.

In: American Journal of Hematology, Vol. 84, No. 9, 09.2009, p. 584-588.

Research output: Contribution to journalArticle

Ageno, W, Garcia, D, Aguilar, MI, Douketis, J, Finazzi, G, Imberti, D, Iorio, A, Key, NS, Lim, W, Marietta, M, Prisco, D, Sarode, R, Testa, S, Tosetto, A & Crowther, M 2009, 'Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2: Treatment', American Journal of Hematology, vol. 84, no. 9, pp. 584-588. https://doi.org/10.1002/ajh.21469
Ageno, Walter ; Garcia, David ; Aguilar, Maria I. ; Douketis, James ; Finazzi, Guido ; Imberti, Davide ; Iorio, Alfonso ; Key, Nigel S. ; Lim, Wendy ; Marietta, Marco ; Prisco, Domenico ; Sarode, Ravi ; Testa, Sophie ; Tosetto, Alberto ; Crowther, Mark. / Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2 : Treatment. In: American Journal of Hematology. 2009 ; Vol. 84, No. 9. pp. 584-588.
@article{d9b14c314f894ad1a23828a711ea1299,
title = "Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2: Treatment",
abstract = "Major bleeding complicates oral vitamin K antagonist therapy in 1-3{\%} of patients annually. However, there is a paucity of published research, which provides evidence to guide management of bleeding. To assist physicians dealing with these potentially serious events in their daily clinical practice, we assembled a panel of international experts and posed them a series of focused clinical questions. The experts were asked to perform a systematic literature review and summarize the results of that review within the context of their clinical question. In most cases, data were lacking and the experts were asked to supplement their answer with clinical expertise. To minimize bias, the reviews were vetted by members of the Italian Society for Studies on Hemostasis and Thrombosis, the Federation of Centers for the Diagnosis of Thrombosis and Surveillance of Antithrombotic Therapies, and the Anticoagulation Forum. Our goal in this project is to provide {"}best evidence{"} to assist clinicians faced with actively bleeding patients.",
author = "Walter Ageno and David Garcia and Aguilar, {Maria I.} and James Douketis and Guido Finazzi and Davide Imberti and Alfonso Iorio and Key, {Nigel S.} and Wendy Lim and Marco Marietta and Domenico Prisco and Ravi Sarode and Sophie Testa and Alberto Tosetto and Mark Crowther",
year = "2009",
month = "9",
doi = "10.1002/ajh.21469",
language = "English (US)",
volume = "84",
pages = "584--588",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2

T2 - Treatment

AU - Ageno, Walter

AU - Garcia, David

AU - Aguilar, Maria I.

AU - Douketis, James

AU - Finazzi, Guido

AU - Imberti, Davide

AU - Iorio, Alfonso

AU - Key, Nigel S.

AU - Lim, Wendy

AU - Marietta, Marco

AU - Prisco, Domenico

AU - Sarode, Ravi

AU - Testa, Sophie

AU - Tosetto, Alberto

AU - Crowther, Mark

PY - 2009/9

Y1 - 2009/9

N2 - Major bleeding complicates oral vitamin K antagonist therapy in 1-3% of patients annually. However, there is a paucity of published research, which provides evidence to guide management of bleeding. To assist physicians dealing with these potentially serious events in their daily clinical practice, we assembled a panel of international experts and posed them a series of focused clinical questions. The experts were asked to perform a systematic literature review and summarize the results of that review within the context of their clinical question. In most cases, data were lacking and the experts were asked to supplement their answer with clinical expertise. To minimize bias, the reviews were vetted by members of the Italian Society for Studies on Hemostasis and Thrombosis, the Federation of Centers for the Diagnosis of Thrombosis and Surveillance of Antithrombotic Therapies, and the Anticoagulation Forum. Our goal in this project is to provide "best evidence" to assist clinicians faced with actively bleeding patients.

AB - Major bleeding complicates oral vitamin K antagonist therapy in 1-3% of patients annually. However, there is a paucity of published research, which provides evidence to guide management of bleeding. To assist physicians dealing with these potentially serious events in their daily clinical practice, we assembled a panel of international experts and posed them a series of focused clinical questions. The experts were asked to perform a systematic literature review and summarize the results of that review within the context of their clinical question. In most cases, data were lacking and the experts were asked to supplement their answer with clinical expertise. To minimize bias, the reviews were vetted by members of the Italian Society for Studies on Hemostasis and Thrombosis, the Federation of Centers for the Diagnosis of Thrombosis and Surveillance of Antithrombotic Therapies, and the Anticoagulation Forum. Our goal in this project is to provide "best evidence" to assist clinicians faced with actively bleeding patients.

UR - http://www.scopus.com/inward/record.url?scp=69549112683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69549112683&partnerID=8YFLogxK

U2 - 10.1002/ajh.21469

DO - 10.1002/ajh.21469

M3 - Article

C2 - 19610020

AN - SCOPUS:69549112683

VL - 84

SP - 584

EP - 588

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 9

ER -